Micro Nova Pharmaceuticals IND Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: Micro Nova Pharmaceuticals IND Pharmaceutical Import Records from India — 6 Products, $3.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Micro Nova Pharmaceuticals IND — Pharmaceutical Importer Profile (2026) | 6 Products, $3.7M Trade | TransData Nexus

Micro Nova Pharmaceuticals IND

Pharmaceutical Importer · Nigeria · Diuretics Focus · $3.7M Total Trade · DGFT Verified

Micro Nova Pharmaceuticals IND is a pharmaceutical importer based in Nigeria with a total trade value of $3.7M across 6 products in 5 therapeutic categories. Based on 100 verified import shipments from Indian Customs (DGFT) records, Micro Nova Pharmaceuticals IND is the #1 buyer in 1 product including Torsemide. Micro Nova Pharmaceuticals IND sources from 1 verified Indian supplier, with Micro Labs Limited accounting for 100.0% of imports.

Micro Nova Pharmaceuticals IND — Import Portfolio & Supplier Network

Micro Nova Pharmaceuticals IND import network — 6 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Micro Nova Pharmaceuticals IND?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Micro Labs Limited	$18.2M	677	100.0%

Micro Nova Pharmaceuticals IND sources from 1 verified Indian supplier across 581 distinct formulations. The sourcing is highly concentrated — Micro Labs Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Micro Nova Pharmaceuticals IND Import?

Formulation	Value	Ships
Misopt (drozolamide 2%w/v and timolol	$200.0K	4
Arbitel 80 h ( (telmisartan 80MG + hydroclorothzide 12.5MG tablets) ( 3x10 s ) (qty-32242.000 )	$200.0K	4
Dapzin 10 dapagliflozin 10MG tablets 3x	$150.0K	3
Micropost eye drops(travoprost ophthalmic solution USP)( 5mlx71370=71370 nos )	$149.8K	3
Misopt eye drops (drozolamide 2%w/v andtimolol maleate 0.5%w/v ) ( 5ML ) ( qty-71400.000 )	$135.1K	3
Novamentine 625 - amoxicillin 500MG+clavulanic acid 125MG tablets BP (2x7's) (qty-111700.00	$117.8K	3
Novamentine 625 (amoxicillin 500MG+clavulanic acid 125mgtablets BP)(2x7s)(qty-108200	$114.6K	3
Syschol 500 (citicoline tablets 500MG)	$101.0K	3
Micropost eye drops (travoprost	$100.0K	2
Plagerine (clopidogrel 75MG tablets)	$100.0K	2
Plagerine (clopidogrel 75MG USP tablets)	$100.0K	2
Amoxicillin 250MG+clavulanic acid 125MG	$100.0K	2
Torsinex 20 torsemide 20MG tablets 3	$100.0K	2
Microcef 500 (cefuroxime axetil 500MG	$98.3K	3
Arbitel - 40 (telmisartan 40MG tablets)	$96.6K	3

Import Portfolio — Top 6 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Torsemide	Diuretics	$1.1M	34	6.1%	1
2	Dapagliflozin	Advanced Diabetes Medications	$950.0K	19	1.9%	9
3	Folic	Nutritional Supplements	$612.6K	17	1.1%	10
4	Itraconazole	Antifungals	$410.1K	11	1.5%	16
5	Moxifloxacin	Advanced Antibiotics	$300.0K	6	0.9%	8
6	Ornidazole	Advanced Antibiotics	$283.2K	13	1.6%	6

Micro Nova Pharmaceuticals IND imports 6 pharmaceutical products across 5 categories into Nigeria totaling $3.7M. The company is the #1 buyer for 1 product: Torsemide.

Micro Nova Pharmaceuticals IND — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Micro Nova Pharmaceuticals Industrial Limited, established on June 19, 2008, is a Nigerian pharmaceutical company specializing in the importation and distribution of finished pharmaceutical formulations. Headquartered at Plot 3, Billings Way, Oregun Industrial Estate, Ikeja, Lagos State, Nigeria, the company operates as a private entity limited by shares. Its primary focus is on sourcing and supplying a diverse range of pharmaceutical products to meet the healthcare needs of the Nigerian population.

In its role within Nigeria's pharmaceutical distribution network, Micro Nova Pharmaceuticals serves as a key importer, facilitating the availability of essential medications across the country. The company's strategic partnerships with reputable international manufacturers enable it to offer a comprehensive portfolio of pharmaceutical products, thereby contributing significantly to the healthcare sector's growth and development.

2Distribution Network

Micro Nova Pharmaceuticals operates from its central warehouse located in Ikeja, Lagos State, Nigeria. While specific details regarding additional warehouse locations and logistics capabilities are not publicly disclosed, the company's strategic position in Lagos—a major commercial hub—suggests a well-established distribution network capable of efficiently serving the Nigerian market. The proximity to key ports and transportation infrastructure likely facilitates timely and effective delivery of pharmaceutical products throughout the country.

3Industry Role

Within Nigeria's pharmaceutical supply chain, Micro Nova Pharmaceuticals functions primarily as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international manufacturers, the company ensures the availability of a wide array of medications to meet the diverse healthcare needs of the Nigerian population. This role is crucial in bridging the gap between global pharmaceutical production and local market demand, thereby enhancing access to quality healthcare products.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Micro Nova Pharmaceuticals IND

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Micro Nova Pharmaceuticals demonstrates a high degree of sourcing concentration, with a total import value of $3.7 million USD from India, accounting for 100 shipments and encompassing 581 unique formulations. The company's exclusive partnership with a single supplier, Micro Labs Limited, indicates a strategic choice to maintain a focused and streamlined supply chain. This approach may offer benefits such as consistent product quality, favorable pricing, and simplified logistics. However, the lack of diversification introduces potential risks, including vulnerability to supply disruptions or changes in supplier dynamics. The stability of this relationship is crucial for maintaining uninterrupted access to essential pharmaceutical products.

2Supply Chain Resilience

The resilience of Micro Nova Pharmaceuticals' supply chain is closely tied to its exclusive sourcing arrangement with Micro Labs Limited. While this partnership may offer advantages in terms of product consistency and pricing, it also presents challenges. The absence of backup suppliers means that any disruptions affecting Micro Labs Limited—such as production issues, regulatory changes, or logistical challenges—could directly impact Micro Nova Pharmaceuticals' ability to meet market demand. Additionally, the company's reliance on a single supplier for 92.3% of its imports suggests limited diversification in its product formulations, which could affect its capacity to adapt to changing market needs or regulatory requirements.

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) serves as the primary regulatory authority overseeing the importation, distribution, and use of pharmaceutical products. Established under Decree No. 15 of 1993 and amended by Decree No. 19 of 1999, NAFDAC operates under the National Agency for Food and Drug Administration and Control Act Cap N1, Laws of the Federation of Nigeria (LFN), 2004. This agency is responsible for ensuring that all pharmaceutical products meet established standards for quality, efficacy, and safety before they are permitted for sale and distribution within Nigeria. (freyrsolutions.com.ng)

2Import Licensing & GMP

To import pharmaceutical products into Nigeria, companies must obtain an import permit from NAFDAC. This process involves submitting relevant documentation, including a Certificate of Pharmaceutical Product (CPP), a Free Sale Certificate, and product labeling information. Additionally, the imported drugs must meet Nigeria’s quality standards to ensure public safety. The Good Manufacturing Practice (GMP) certification of the manufacturing facility is a critical component of the import approval process, as it attests to the quality and safety of the pharmaceutical products.

Quality & Labeling

Micro Nova Pharmaceuticals IND — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Micro Nova Pharmaceuticals' product portfolio focuses on therapeutic areas such as diuretics, advanced diabetes medications, and nutritional supplements. The company's top five imported products include Torsemide, Dapagliflozin, Folic Acid, Itraconazole, and Moxifloxacin, which collectively account for 92.3% of its total imports. This concentration indicates a strategic emphasis on addressing prevalent health conditions in Nigeria, such as hypertension, diabetes, and nutritional deficiencies. The market demand for these products is driven by the high incidence of these conditions and the need for effective management and treatment options.

2Sourcing Profile

Micro Nova Pharmaceuticals primarily sources generic pharmaceutical products from India, with a particular focus on formulations manufactured by Micro Labs Limited. The company's preference for finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, aligns with its strategy to provide ready-to-use medications to the Nigerian market. This sourcing approach ensures a consistent supply of quality products and leverages India's established reputation in pharmaceutical manufacturing.

3Market Positioning

Seller's Guide — How to Become a Supplier to Micro Nova Pharmaceuticals IND

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Nigerian market by establishing partnerships with Micro Nova Pharmaceuticals. Given the company's concentrated sourcing strategy, introducing alternative suppliers could enhance supply chain resilience and provide additional options for the Nigerian market. Potential gaps in Micro Nova Pharmaceuticals' current sourcing include diversification of suppliers and formulations, which could be addressed by new entrants offering complementary products or formulations.

2Requirements & Qualifications

Indian exporters seeking to supply Micro Nova Pharmaceuticals and the Nigerian market must ensure that their products are registered with NAFDAC and comply with the agency's quality standards. Manufacturers should possess valid GMP certifications recognized by NAFDAC, and products must meet the labeling and packaging requirements stipulated by Nigerian regulations. Additionally, exporters should be prepared to provide necessary documentation, such as Certificates of Pharmaceutical Product (CPP) and Free Sale Certificates, to facilitate the import approval process.

3How to Approach

Frequently Asked Questions — Micro Nova Pharmaceuticals IND

What products does Micro Nova Pharmaceuticals IND import from India?

Micro Nova Pharmaceuticals IND imports 6 pharmaceutical products across 5 categories. Top imports: Torsemide ($1.1M), Dapagliflozin ($950.0K), Folic ($612.6K), Itraconazole ($410.1K), Moxifloxacin ($300.0K).

Who supplies pharmaceuticals to Micro Nova Pharmaceuticals IND from India?

Micro Nova Pharmaceuticals IND sources from 1 verified Indian suppliers. The primary supplier is Micro Labs Limited (100.0% of imports, $18.2M).

What is Micro Nova Pharmaceuticals IND's total pharmaceutical import value?

Micro Nova Pharmaceuticals IND's total pharmaceutical import value from India is $3.7M, based on 100 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Micro Nova Pharmaceuticals IND focus on?

Micro Nova Pharmaceuticals IND imports across 5 categories. The largest: Diuretics (30.4%), Advanced Diabetes Medications (25.9%), Nutritional Supplements (16.7%).

Get Full Micro Nova Pharmaceuticals IND Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.